FDA Panel Urges Stronger Antidepressant Warning
An advisory committee recommends the FDA issue stronger warnings about the use of antidepressants called SSRIs in children and teenagers. The panel concludes that available research suggests the drugs can double the incidence of suicidal thoughts and attempts. Hear NPR's Joanne Silberner.
Copyright 2004 NPR